Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia - No Study Results Posted

Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia (ACT3)

This study has been completed.

Study NCT00436683 Information provided by Ineos Healthcare Limited

First Received: February 16, 2007 Last Updated: July 21, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2008
Primary Completion Date:	January 2008 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: July 21, 2009